A memory clinic is usually part of a hospital. The staff are specialists in finding out what is causing a person’s memory problems and diagnosing dementia. They will perform some in-depth tests and ...

The following questions will help us to understand how well our information worked for you, what difference it’s made and what kind of information you’d like to see in the future.

Find out about five major findings of dementia research over the years, including new treatments and potential ways of diagnosing dementia. Click on each box for more information. 1. The discovery of ...

Find out the 10 most important facts and statistics about dementia and dementia research. Click on each fact for more information. 1. Dementia is not a disease itself. Expand The word ‘dementia’ is a ...

Although often thought of as a condition that only affects older people, it is estimated that around 70,800 people with dementia in the UK are under 65. This is called young onset dementia, and you ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Our brains control everything we think, feel, remember and do. There are diseases that stop a person’s brain from working properly. When a person has one of these diseases, they may have problems with ...

This week the Government revealed its Spending Review - we dive into what the settlement means for progress on dementia.

The information on these pages is for anyone who is concerned about symptoms of dementia, and for those who would like more information about how dementia is diagnosed. Anyone concerned about their ...

There are nearly 1 million people living with dementia in the UK, the majority of these are over the age of 65 and living with other health conditions. This can mean that they are more vulnerable to ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...